The role of implantable cardioverter-defibrillators and sudden cardiac death prevention: indications, device selection, and outcome.

Goldenberg, Ilan; Huang, David T; Nielsen, Jens Cosedis

Goldenberg, Ilan; Huang, David T; Nielsen, Jens Cosedis.

Affiliation

Goldenberg I; Division of Cardiology, Department of Medicine, The Clinical Cardiovascular Research Center, University of Rochester Medical Center, 265 Crittenden Blvd CU 420653, Rochester, NY 14642, USA.
Huang DT; Division of Cardiology, Department of Medicine, The Clinical Cardiovascular Research Center, University of Rochester Medical Center, 265 Crittenden Blvd CU 420653, Rochester, NY 14642, USA.
Nielsen JC; Department of Cardiology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus N, Denmark.

Eur Heart J ; 41(21): 2003-2011, 2020 06 01.

Article in En | MEDLINE | ID: mdl-31713598

Subject(s)

Cardiac Resynchronization Therapy; Defibrillators, Implantable; Heart Failure; Tachycardia, Ventricular; Death, Sudden, Cardiac/prevention & control; Heart Failure/complications; Heart Failure/therapy; Humans; Tachycardia, Ventricular/complications; Tachycardia, Ventricular/therapy

Key words

ICD; Primary prevention; Sudden cardiac death; Ventricular tachyarrhymias

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Tachycardia, Ventricular / Defibrillators, Implantable / Cardiac Resynchronization Therapy / Heart Failure Type of study: Clinical_trials Limits: Humans Language: En Journal: Eur Heart J Year: 2020 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google